Shuting Han

1.2k total citations
23 papers, 472 citations indexed

About

Shuting Han is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Shuting Han has authored 23 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Shuting Han's work include RNA modifications and cancer (3 papers), Advances in Oncology and Radiotherapy (3 papers) and COVID-19 and healthcare impacts (3 papers). Shuting Han is often cited by papers focused on RNA modifications and cancer (3 papers), Advances in Oncology and Radiotherapy (3 papers) and COVID-19 and healthcare impacts (3 papers). Shuting Han collaborates with scholars based in Singapore, China and Germany. Shuting Han's co-authors include Hongchuan Jin, Xian Wang, Miaoqin Chen, Yiran Zhu, Ping Song, Liyuan Zhu, Lifeng Feng, Dongjun Dai, Vivian Y. Shin and Wenxia Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Langmuir and Analytical Biochemistry.

In The Last Decade

Shuting Han

20 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuting Han Singapore 11 258 179 157 58 57 23 472
Kwan Chee Allen Chan Hong Kong 7 177 0.7× 169 0.9× 203 1.3× 37 0.6× 85 1.5× 8 545
Cristian Virgil Lungulescu Romania 11 163 0.6× 111 0.6× 142 0.9× 24 0.4× 59 1.0× 43 406
Silvia Camera Italy 10 96 0.4× 71 0.4× 164 1.0× 102 1.8× 67 1.2× 27 388
Fabrizio Citarella Italy 8 143 0.6× 159 0.9× 227 1.4× 27 0.5× 139 2.4× 26 420
Jiangdong Xiang China 10 138 0.5× 115 0.6× 107 0.7× 45 0.8× 47 0.8× 25 371
Vivi M. Srivastava India 12 424 1.6× 43 0.2× 125 0.8× 20 0.3× 19 0.3× 29 668
Audrey Turchick United States 8 124 0.5× 72 0.4× 104 0.7× 31 0.5× 41 0.7× 12 266
Rahul Bhome United Kingdom 13 437 1.7× 341 1.9× 221 1.4× 74 1.3× 64 1.1× 29 743
Vincent Gagné Canada 12 202 0.8× 56 0.3× 145 0.9× 18 0.3× 18 0.3× 25 548
Marie Viala France 10 68 0.3× 116 0.6× 185 1.2× 20 0.3× 97 1.7× 25 418

Countries citing papers authored by Shuting Han

Since Specialization
Citations

This map shows the geographic impact of Shuting Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuting Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuting Han more than expected).

Fields of papers citing papers by Shuting Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuting Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuting Han. The network helps show where Shuting Han may publish in the future.

Co-authorship network of co-authors of Shuting Han

This figure shows the co-authorship network connecting the top 25 collaborators of Shuting Han. A scholar is included among the top collaborators of Shuting Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuting Han. Shuting Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhijun, Yao Deng, Hailei Wang, et al.. (2025). Functionalization of 2H-MoS2 with Pt Nanoclusters for HER in Alkaline Solutions and Supercapacitors. Langmuir. 41(22). 14265–14274. 3 indexed citations
3.
Han, Shuting, et al.. (2023). Pathogenesis and therapeutic implications of EBV-associated epithelial cancers. Frontiers in Oncology. 13. 1202117–1202117. 10 indexed citations
4.
Loke, Kelvin Siu Hoong, et al.. (2023). A case of metastatic lymphoepithelial carcinoma of parotid gland identified on 68gallium DOTA-[Tyr3] octreotate PET CT. BJR|case reports. 10(1). uaad011–uaad011.
5.
Loke, Kelvin Siu Hoong, et al.. (2023). 68Ga-DOTATATE PET/CT of Metastatic Lymphoepithelial Carcinoma of Parotid Gland. Clinical Nuclear Medicine. 48(12). 1056–1058.
6.
Han, Shuting, et al.. (2022). The distinct clinical trajectory, metastatic sites, and immunobiology of microsatellite-instability-high cancers. Frontiers in Genetics. 13. 933475–933475. 9 indexed citations
7.
Han, Shuting, Qingyuan Zhuang, Jianbang Chiang, et al.. (2022). Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis. BMJ Open. 12(2). e044661–e044661. 34 indexed citations
8.
Han, Shuting, Liyuan Zhu, Yiran Zhu, et al.. (2021). Targeting ATF4-dependent pro-survival autophagy to synergize glutaminolysis inhibition. Theranostics. 11(17). 8464–8479. 67 indexed citations
9.
Han, Shuting, et al.. (2021). Epstein–Barr Virus Epithelial Cancers—A Comprehensive Understanding to Drive Novel Therapies. Frontiers in Immunology. 12. 734293–734293. 41 indexed citations
10.
Chiang, Jianbang, Valerie Shiwen Yang, Shuting Han, et al.. (2021). Oncology workload in a tertiary hospital during the COVID-19 pandemic. SHILAP Revista de lepidopterología. 31. 2 indexed citations
11.
Han, Shuting, et al.. (2020). Tailoring precision immunotherapy: coming to a clinic soon?. ESMO Open. 5. e000631–e000631. 11 indexed citations
12.
Chiang, Jianbang, Valerie Shiwen Yang, Shuting Han, et al.. (2020). Minimizing transmission of COVID-19 while delivering optimal cancer care in a National Cancer Centre. Journal of Cancer Policy. 25. 100241–100241. 11 indexed citations
13.
Dai, Dongjun, et al.. (2020). Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma. Medicine. 99(32). e21478–e21478. 6 indexed citations
14.
Zhu, Liyuan, Yiran Zhu, Shuting Han, et al.. (2019). Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer. Cell Death and Disease. 10(6). 383–383. 156 indexed citations
15.
Han, Shuting, Yan Cui, & Dario Lucas Helbing. (2019). Differential effects of hydrogen peroxide (H2O2) treatment on epitope recognition in western blotting. Analytical Biochemistry. 586. 113417–113417. 4 indexed citations
16.
Han, Shuting, Who-Whong Wang, Esdy Rozali, & Han Chong Toh. (2019). Defining precision cellular immunotherapy—seeking biomarkers to predict and optimize outcomes of T cell therapies in cancer. 2. 25–25. 1 indexed citations
17.
Han, Shuting & Han Chong Toh. (2018). The empowerment of all modalities against cancer. Singapore Medical Journal. 59(11). 560–561. 1 indexed citations
18.
Dai, Dongjun, Shuting Han, Ling Li, et al.. (2018). Anemia is associated with poor outcomes of metastatic castration-resistant prostate cancer, a systematic review and meta-analysis.. PubMed. 10(12). 3877–3886. 17 indexed citations
19.
Han, Shuting, et al.. (2012). Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta-analysis of randomised controlled trials. International Journal of Clinical Practice. 66(2). 199–209. 55 indexed citations
20.
Du, Shuxin & Shuting Han. (2006). Congestion control of multimedia stream for ATM multiplexers using neural networks. 3. 2206–2211. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026